Sánchez-López Elsa, Rodriguez-Vita Juan, Cartier Cecile, Rupérez Monica, Esteban Vanesa, Carvajal Gisselle, Rodrígues-Díez Raquel, Plaza Juan José, Egido Jesús, Ruiz-Ortega Marta
Cellular Biology in Renal Diseases Laboratory, Fundación Jiménez Díaz, Universidad Autónoma Madrid, Madrid, Spain.
Am J Physiol Renal Physiol. 2008 Jan;294(1):F149-60. doi: 10.1152/ajprenal.00129.2007. Epub 2007 Nov 7.
Connective tissue growth factor (CTGF) is overexpressed in kidney diseases associated with extracellular matrix accumulation. Angiotensin II (ANG II) participates in renal fibrosis by the upregulation of growth factors, including CTGF, and extracellular matrix proteins, such as type IV collagen. During renal injury, ANG II and the macrophage-produced cytokine interleukin-1beta (IL-1beta) may be present simultaneously in the glomerular environment. However, there are no studies about the interaction between ANG II and IL-1beta in renal fibrosis. For this reason, in cultured mesangial cells (MC), we investigated whether IL-1beta could regulate ANG II-mediated collagen accumulation and the mechanisms underlying this process. In MC, CTGF is a downstream mediator of type IV collagen production induced by ANG II. IL-1beta did not increase the production of CTGF and type IV collagen but significantly inhibited ANG II-induced CTGF and type IV collagen overexpression. Moreover, IL-1beta also inhibited type IV collagen upregulation caused by exogenous recombinant CTGF. Matrix metalloproteinase-9 (MMP-9) is the main enzyme involved in type IV collagen degradation. In MC, coincubation of IL-1beta and ANG II caused a synergistic increase in MMP-9 gene expression and activity, associated with type IV collagen inhibition. The described IL-1beta effects were dependent on activation of ERK/MAPK but independent p38-MAPK, JNK, phosphatidylinositol 3-kinase/Akt, and Rho-associated kinase pathways. In summary, these data indicate that IL-1beta inhibited ANG II-mediated type IV collagen production, via CTGF downregulation, and increased type IV collagen degradation, through MMP-9 upregulation. Our in vitro data show that the proinflammatory cytokine IL-1beta abrogates ANG II-induced CTGF production, describing antagonistic activities of proinflammatory cytokines on ANG II actions.
结缔组织生长因子(CTGF)在与细胞外基质积聚相关的肾脏疾病中过度表达。血管紧张素II(ANG II)通过上调包括CTGF在内的生长因子和细胞外基质蛋白(如IV型胶原)参与肾纤维化。在肾损伤期间,ANG II和巨噬细胞产生的细胞因子白细胞介素-1β(IL-1β)可能同时存在于肾小球环境中。然而,关于ANG II和IL-1β在肾纤维化中的相互作用尚无研究。因此,在培养的系膜细胞(MC)中,我们研究了IL-1β是否能调节ANG II介导的胶原积聚及其潜在机制。在MC中,CTGF是ANG II诱导IV型胶原产生的下游介质。IL-1β并未增加CTGF和IV型胶原的产生,但显著抑制ANG II诱导的CTGF和IV型胶原过表达。此外,IL-1β还抑制外源性重组CTGF引起的IV型胶原上调。基质金属蛋白酶-9(MMP-9)是参与IV型胶原降解的主要酶。在MC中,IL-1β和ANG II共同孵育导致MMP-9基因表达和活性协同增加,与IV型胶原抑制相关。上述IL-1β的作用依赖于ERK/MAPK的激活,但不依赖于p38-MAPK、JNK、磷脂酰肌醇3-激酶/Akt和Rho相关激酶途径。总之,这些数据表明,IL-1β通过下调CTGF抑制ANG II介导的IV型胶原产生,并通过上调MMP-9增加IV型胶原降解。我们的体外数据表明,促炎细胞因子IL-1β消除了ANG II诱导的CTGF产生,描述了促炎细胞因子对ANG II作用的拮抗活性。